XML 38 R12.htm IDEA: XBRL DOCUMENT v3.20.4
TDCC Consolidated Statements of Equity Statement - USD ($)
$ in Millions
Total
Common Stock
Add'l Paid-in Capital
Retained Earnings [Member]
Accumulated Other Comprehensive Loss
Unearned ESOP
The Dow Chemical Company
The Dow Chemical Company
Common Stock
The Dow Chemical Company
Add'l Paid-in Capital
The Dow Chemical Company
Retained Earnings [Member]
The Dow Chemical Company
Accumulated Other Comprehensive Loss
The Dow Chemical Company
Unearned ESOP
Dow Inc. [Member]
The Dow Chemical Company
Add'l Paid-in Capital
Dow Inc. [Member]
The Dow Chemical Company
Retained Earnings [Member]
DowDuPont
The Dow Chemical Company
Add'l Paid-in Capital
DowDuPont
The Dow Chemical Company
Retained Earnings [Member]
Beginning balance at Dec. 31, 2017   $ 0 $ 6,553 $ 33,742 $ (8,591) $ (189)   $ 0 $ 6,553 $ 33,742 $ (8,591) $ (189)        
Issuance of parent company stock     112                   $ 0   $ 112  
Stock-based compensation and allocation of ESOP shares     377     55     377     55        
Other     0 19         0 (19)            
Net income (loss) available for The Dow Chemical Company common stockholder $ 4,641     4,641     $ 4,641     4,641            
Dividends to parent       (3,711)                   $ (3,711)   $ 0
Settlements and transfers related to separation from DowDuPont Inc. 240     (182) 0   240     (182) 0          
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement [Member]       989 (1,037)         989 (1,037)          
Other comprehensive income (loss) (257)       (257)           (257)          
ESOP shares acquired           0           0        
Ending balance at Dec. 31, 2018 33,621 0 7,042 35,460 (9,885) (134) 33,621 0 7,042 35,460 (9,885) (134)        
The Dow Chemical Company’s stockholder's equity 32,483           32,483                  
Noncontrolling interests 1,138           1,138                  
Issuance of parent company stock     28                   65   28  
Stock-based compensation and allocation of ESOP shares     235     45     235     45        
Other     37 14         (37) (14)            
Net income (loss) available for The Dow Chemical Company common stockholder (1,359)     (1,359)     (1,237)     (1,237)            
Dividends to parent       (535)                   (535)   (201)
Settlements and transfers related to separation from DowDuPont Inc. (1,935)     (14,806) 793   61     (16,009) 793          
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement [Member]       (151) 0         (151) 0          
Other comprehensive income (loss) (1,154)       (1,154)           (1,154)          
ESOP shares acquired           (2)           (2)        
Ending balance at Dec. 31, 2019 14,094 8 7,325 17,045 (10,246) (91) 14,862 $ 0 7,333 17,313 (10,246) (91)        
The Dow Chemical Company’s stockholder's equity 13,541           14,309                  
Noncontrolling interests 553           553                  
Issuance of parent company stock     0                   $ 108   $ 0  
Stock-based compensation and allocation of ESOP shares     162     42     162     42        
Other     0 15         0 (15)            
Net income (loss) available for The Dow Chemical Company common stockholder 1,225     1,225     1,235     1,235            
Dividends to parent       0                   $ 0   $ (2,233)
Settlements and transfers related to separation from DowDuPont Inc. 0     177 0   0     0 0          
Stockholders' Equity, Period Increase (Decrease) | Adjustments for New Accounting Pronouncement [Member]       0 0         0 0          
Other comprehensive income (loss) (609)       (609)           (609)          
ESOP shares acquired           0           0        
Ending balance at Dec. 31, 2020 13,005 $ 8 $ 7,595 $ 16,361 $ (10,855) $ (49) 13,569   $ 7,603 $ 16,300 $ (10,855) $ (49)        
The Dow Chemical Company’s stockholder's equity 12,435           12,999                  
Noncontrolling interests $ 570           $ 570